Silicone gel sheets are widely used to treat keloids and hypertrophic scars. ScarclinicTM is a type
of silicone gel sheet developed in Korea, and has been shown to improve the appearance of scars.
However, ScarclinicTM has demerits that include weak adhesiveness, a color that differs from skin,
and too great a thickness. Scarclinic-thinTM was recently developed with these disadvantages in
mind. The purpose of this pilot study was to compare the effects of Scarclinic-thinTM and ScarclinicTM
on scar appearance and wearer’s comfort. From April 2010 to May 2010, Scarclinic-thinTM and
ScarclinicTM were applied to treat a single scar in each of 8 patients. One half of each scar was treated
with Scarclinic-thinTM and the other with ScarclinicTM. After 3 months, scar quality and wearer’s comfort
were evaluated using the Vancouver Scar Scale (VSS) and an objective self-assessment scale
(OSAS). Mean Vancouver Scar Scale scores for ScarclinicTM and Scarclinic-thinTM at 3 months were
3.4 ± 1.3 and 3.3 ± 2.0, respectively, and mean objective self-assessment scale scores were 21.7 ±
4.5 and 22.3 ± 2.9, respectively. No statistically significant difference was observed between
ScarclinicTM and Scarclinic-thinTM in terms of Vancouver Scar Scale or objective self-assessment
scale scores (p=0.83 and 0.70, respectively). Scarclinic-thinTM and ScarclinicTM are similar in terms of
their scar improving effects and wearer’s comfort.